ArticleDiabetologia2024

Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.

Aikaterini Eleftheriadou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.